{name}
{subtitle}
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
city
~4 mi. (Bendigo, Australia, +126 more cities)
facility
Local Institution
drug
nivolumab, +2 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~75 mi. (Wendouree, Australia, +89 more cities)
facility
Ballarat Oncology & Haematology
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +1 more drug
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
city
~77 mi. (Ballarat, Australia, +271 more cities)
facility
Ballarat Base Hospital
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +2 more types
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery
city
~77 mi. (Ballarat, Australia, +174 more cities)
facility
Ballarat Health Services-Medical Oncology
drug
chemoradiotherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~77 mi. (Ballarat, Australia, +151 more cities)
facility
GSK Investigational Site
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type